InvestorsHub Logo
Followers 971
Posts 382979
Boards Moderated 18
Alias Born 06/24/2011

Re: None

Tuesday, 09/19/2017 9:25:00 AM

Tuesday, September 19, 2017 9:25:00 AM

Post# of 177043
$PSID SELRAY BEACH, Fla., Sept. 19, 2017 (GLOBE NEWSWIRE) -- One of the biggest barriers to delivering rapid diagnosis and care during a biological outbreak is about to be eliminated, said Lyle L. Probst, President, CEO and Founder of PositiveID Corporation’s (PSID) ExcitePCR subsidiary.
Internal Sample Preparation, Small Size and Rapid Results Differentiate the FireflyDX Systems, says Lyle Probst During BioWatch Panel
https://finance.yahoo.com/news/internal-sample-preparation-small-size-120000072.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.